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thyroidism (PHPT) present a challenge in the clinical and surgical decision-making for these pa-
tients. In this study, we aimed to evaluate concomitant thyroid pathologies in patients who
underwent operations for PHPT to determine the sensitivity (Sn) of neck ultrasonography
(US) and Tc99m sestamibi scintigraphy in detecting parathyroid adenoma. We also aimed to
determine the clinical impact of preoperative neck US in patients with PHPT.
Methods: One hundred thirty-eight patients with PHPT were included in this retrospective
study. All patients underwent preoperative Tc99m sestamibi scintigraphy and/or thyroid US.
Nodules of 1 cm or <1 cm with suspicious US features underwent fine needle aspiration bi-
opsy (FNAB).
Results: Preoperative thyroid US revealed that 93.5% of patients with PHPT had thyroid abnor-
malities and 66.7% of patients had at least one thyroid nodule. Postoperative histopathology
results showed that 79.2% of patients had benign thyroid disease and 20.8% of patients had ma-
lignant thyroid disease. In the detection of parathyroid adenoma, US had 89.1% Sn and Tc99m
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reserved.1. Introduction
Primary hyperparathyroidism (PHPT) is the third most
common endocrine disorder.1,2 It is twice as common in
women, and its incidence increases with age with a peak in
the fifth to sixth decades of life.1,3,4 It is caused by one or
more overactive parathyroid glands, which results in
elevated parathyroid hormone (PTH) and serum calcium
(Ca) levels.5
Coexistent thyroid pathology found during neck explo-
ration in patients with PHPT has been well described.6 The
incidence of PHPT with coexistent thyroid diseases ranges
from 17% to 84% in different studies.2,4,7e12 In addition, the
incidence of synchronous thyroid cancer in patients with
PHPT ranges between 2% and 24%.2,4,7e9,11,12 It is still
controversial whether the association of PHPT and non-
medullary thyroid carcinoma (NMTC) is coincidental or if
pathogenetic mechanisms or risk factors such as irradia-
tion, the goitrogenic effect of Ca or calcitonin, and genetic
factors account for the coexistence of these two
disorders.13
Surgical excision is the only curative treatment for PHPT
and has been shown to be safe and effective for patients of
any age.5 Bilateral neck exploration which allows the sur-
geon to perform a thorough examination of the thyroid
gland and examine the four parathyroid glands was tradi-
tionally performed in the surgical management of
PHPT.11,13,14 This procedure is usually helpful also for the
identification and resection of tissue affected by concom-
itant thyroid disease.11 Advances in imaging procedures
(which provides a definitive preoperative localization of
parathyroid adenomas), improved surgical techniques, and
the use of intraoperative intact PTH measurement have
increased the tendency toward minimally invasive ap-
proaches (MIAs) for parathyroid surgeries.11e13 Because
PHPT is caused by a solitary adenoma in 85e90% of pa-
tients15,16, most patients can be treated with MIAs.14 Such
approaches have potential benefits, such as smaller in-
cisions, lower morbidity, shorter length of hospitalization,
and quick return to preoperative activity; however, a sur-
geon may miss any coexistent thyroid pathology because of
the smaller surgical field.2,5,11,13 Concomitant thyroid pa-
thology in patients with PHPT presents a challenge in the
clinical and surgical decision-making for these patients.11
Early diagnosis and simultaneous surgical treatment,
particularly for thyroid cancer, is the most important part
of management.17 A delayed diagnosis may lead to a second
neck exploration, which is more difficult and associated
with increased complication rates.17 To determine the most
appropriate management for PHPT, it is important to
localize the pathologic parathyroid gland and diagnoseuhaci N, et al., Concomitant thy
.doi.org/10.1016/j.asjsur.2015.10concomitant thyroid disease.18 High-resolution ultrasonog-
raphy (US) and Tc99m sestamibi scintigraphy are widely
accepted methods for the preoperative localization of
parathyroid lesions.5,19 Ultrasonography enables screening
of the thyroid gland while simultaneously localizing the
parathyroid adenoma.17
In this study, we aimed to evaluate concomitant thyroid
pathologies in patients who underwent operations for PHPT
to determine the best surgical strategy in this group of
patients and to determine the clinical impact of preoper-
ative neck US in our center.
2. Materials and methods
2.1. Patients
We retrospectively evaluated patients who underwent
parathyroid surgery for PHPT between January 2010 and
June 2013 in our clinic. All patients underwent preoperative
parathyroid localization by Tc99m sestamibi scintigraphy
and/or neck US. Patients younger than 15 years old and
patients with a previous history of thyroid or parathyroid
operations, percutaneous interventions, or radiotherapy of
the head and neck were excluded from the study. Patients
with a surgical contraindication associated with comorbid
diseases (e.g., cardiovascular or respiratory system dis-
eases) or who refused surgery were also excluded.
In our clinic, all operation indications are administered
with an expert council that consists of surgeons, endocrine
specialists, and nuclear medicine specialists. In this coun-
cil, patients are informed about their operation indications
and the operation types, and they are informed that the
operation type can be changed according the situation in
which the surgeon encounters. Informed consent was ob-
tained from all patients before surgery. The study protocol
followed the tenets of the 1964 Declaration of Helsinki.
2.2. Laboratory
The levels of sensitive thyroid-stimulating hormone (sTSH),
free triiodothyronine (fT3), free thyroxine (fT4), thyroid
autoantibodies [e.g., thyroid peroxidase antibody (anti-
TPO) and thyroglobulin antibody (anti-Tg)], and thyroglob-
ulin were measured in all patients using chem-
iluminescence methods (Immulite 2000; Diagnostic
Products Corporation, Los Angeles, CA; and UniCel DxI 800;
Beckman Coulter, Brea, CA). The normal ranges for sTSH,
fT3, fT4, anti-Tg, and anti-TPO were 0.4e4 mIU/mL,
1.57e4.71 pg/mL, 0.61e1.12 ng/dL, <30 U/mL, and
<10 U/mL, respectively. The serum levels of Ca, albumin,roid lesions in patients with primary hyperparathyroidism, Asian
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urine Ca and phosphorus excretion were evaluated (normal
levels are 8.6e10 mg/dL, 3.5e5.2 g/dL, 2.5e4.5 mg/dL,
10e80 mg/L, 15e65 pg/mL, 100e300 mg/day, and
0.4e1.3 g/day, respectively). In addition, dual energy X-ray
absorptiometry (DEXA) and renal US were performed to
evaluate bone mineral density and nephrolithiasis,
respectively.
2.3. Conventional ultrasonography and fine needle
aspiration biopsy
An Esaote color Doppler US system (Model 796FDII; MAG
Technology Co. Ltd., Yung-Ho City, Taipei, Taiwan) and
standard US system with a superficial probe (Model LA523
13e4, 5.5e12.5 MHz) were used. The patient laid supine
with his or her neck in hyperextension, and the skin was
coated with acoustic material. Chronic thyroiditis was
defined when the thyroid gland was diffusely heterogenous
and/or hypoechoic with/without pseudonodules and
fibrotic bands.20
The location, diameter (mm), volume, component (i.e.,
solid, cystic, mixed), echogenicity (i.e., hypoechoic, iso-
echoic, hyperechoic), border regularity, calcification, and
presence of peripheral halo of nodules were evaluated.
Nodules of 1 cm or <1 cm with questionable US features
such as an irregular border, hypoechoic texture, solid
component, the presence of microcalcification, and ante-
roposterior/transverse diameter greater than 1 underwent
fine needle aspiration biopsy (FNAB).21 This procedure was
performed under US guidance using a General Logic Pro 200
system (model 2270968; GE Healthcare, Korea and Seong-
nam SI; Gyeonggi-do, Korea) and a 5.5-MHz to 7.5-MHz su-
perficial probe. Written consent was obtained from all
patients before the FNAB. No anesthetics were applied
before the procedure. For all patients, US-guided FNAB was
performed by an experienced endocrinologist using a 23-
gauge needle and 20-mL syringe.
The US results were classified as normal, chronic
thyroiditis, multinodular goiter/nodular goiter (MNG/NG),
and chronic thyroiditis with MNG/NG.
2.4. Cytological and histopathological examination
Materials obtained by US-guided FNAB were air-dried,
stained with May-Gru¨nwald-Giemsa, and evaluated ac-
cording to the Bethesda system classification.22 The
cytology results were as follows: (1) nondiagnostic, (2)
benign, (3) atypia/follicular lesion of undetermined signif-
icance (AUS/FLUS), (4) follicular neoplasm/suspected
follicular neoplasm, (5) suspected malignancy, and (6)
malignant.23,24 Histopathological evaluation was made in
accordance with the 2004 World Health Organization
criteria.25
2.5. Tc99m Sestamibi scintigraphy
Fifteen mCi of Tc99m methoxy-isobutyl-isonitrile (i.e.,
sestamibi) was intravenously injected. Anterior static im-
ages of the neck and mediastinum were taken 10 minutes
and 3 hours after the injection. At the third hour, to correctPlease cite this article in press as: Cuhaci N, et al., Concomitant thy
Journal of Surgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.10the anatomic correlation and attenuation of the neck re-
gion, computed tomography and/or single-photon emission
computed tomography images were taken. A distinct focus
of increased or separate Tc99m sestamibi uptake relative to
the thyroid gland on either the early or late images (or
both) was considered positive for abnormal parathyroid
tissue.
2.6. Statistical analysis
SPSS 11.5 software (Statistical Packaging of Social Science
for Windows (SPSS Inc., Chicago, IL)) was used for the
analysis of the variables. Descriptive statistics for contin-
uous variables are expressed as the mean  the standard
deviation or as the median (minimumemaximum). The
categorical variables are denoted as the number and
percent (%). Fischer’s chi-square test was used to evaluate
the difference between the groups with regard to the
categorical variables and ManneWhitney U test was used
for the nonparametric variables. We determined sensitivity
of US and methoxy-isobutyl-isonitrile (MIBI). A p value less
than 0.05 was accepted as statistically significant.
3. Results
3.1. Clinical characteristics and preoperative
evaluation of the patients
One hundred fifty-one patients who underwent para-
thyroidectomy were evaluated. Thirteen patients were
excluded from the study because of previous thyroid op-
erations (five patients) and tertiary hyperparathyroidism
(eight patients). The data of 138 patients with PHPT were
finally analyzed in this study. One hundred twenty-four
(89.9%) of the 138 patients were female, and 14 (10.1%)
patients were male. The mean age of the patients was
51.2  10.1 years (range, 22e79 years).
Preoperative laboratory evaluation showed that the
mean level of serum Ca was 11.2  0.77 mg/dL; albumin,
4.2  0.38 g/dL, and phosphorus, 2.5  0.58 mg/dL. Mean
levels of serum PTH and 25-OH vitamin D were
248.5  197.91 pg/mL (range, 80e1515 pg/mL; median,
190 pg/mL) and 17.5  13.89 mg/L, respectively. The mean
24-hour urinary Ca excretion was 389 mg/day. According to
the DEXA and urinary US results, 39.1% of patients had
osteoporosis and 22.5% had nephrolithiasis.
Twelve (8.7%) patients had hypothyroidism and six (4.3%)
patients had thyrotoxicosis. The remaining 120 (87%) pa-
tients had normal thyroid hormones (Table 1). The thyroid
peroxidase antibody positivity rate was 28.3%, and the anti-
Tg positivity rate was 32.6%.
Neck US was performed in all patients preoperatively.
Neck US revealed nine (6.5%) patients had normal thyroid
and 37 (26.8%) patients had chronic thyroiditis. Ninety-two
(66.7%) patients had at least one thyroid nodule: of these,
73 (52.9%) patients had chronic thyroiditis and 19 (13.8%)
patients did not have chronic thyroiditis (Table 1). Nodule
localization was bilateral in 56 (60.9%) patients. The mean
nodule diameter was 12.77  10.58 mm (range
2.3e60.1 mm). Fine needle aspiration biopsy was per-
formed in 58 patients. The FNAB cytological resultsroid lesions in patients with primary hyperparathyroidism, Asian
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Table 1 Preoperative thyroid function and ultrasonogra-
phy findings in patients with primary hyperparathyroidism.
Variables n (%)
Thyroid function
Hypothyroidism 12 (8.7%)
Thyrotoxicosis 6 (4.3%)
Euthyroid 120 (87.0%)
Thyroid US results
Normal 9 (6.5%)
MNG/NG 19 (13.8%)
Chronic thyroiditis þ MNG/NG 73 (52.9%)
Chronic thyroiditis 37 (26.8%)
Site of parathyroid adenoma
Right 68 (49.3%)
Left 69 (50.0%)
Bilateral 1 (0.7%)
Localization of the parathyroid adenoma
Superior 20 (14.5%)
Inferior 118 (85.5%)
MNG, multinodular goiter; NG, nodular goiter; US,
ultrasonography.
Table 3 Operation types and postoperative parathyroid
and thyroid histopathological results.
Variables n (%)
Operation type
Parathyroidectomy 32 (23.2%)
Parathyroidectomy þ
lobectomy/isthmectomy
35 (33%)
Parathyroidectomy þ Total thyroidectomy 71 (67%)
Parathyroid histopathology
Hyperplasia 3 (2.2%)
Adenoma 128 (92.8%)
Carcinoma 1 (0.7%)
Atypical adenoma 6 (4.3%)
Thyroid histopathology
Benign 84 (79.2%)
Malignant 22 (20.8%)
Histopathological features of PTCs
Tumor size
Microcarcinoma 20 (90.91%)
Macrocarcinoma 2 (9.09%)
PTC variant
Classical 19 (86.4%)
Follicular variant 2 (9.1%)
Tall cell variant 1(4.5%)
Vascular invasion d
Capsular invasion 2 (9.1%)
Lymph node metastasis 1 (4.5%)
Multicentricity 7 (31.8)
Extracapsular invasion d
Ipsilateral PTC and parathyroid lesion 14 (63.6%)
PTC, papillary thyroid carcinoma.
The sample comprises 138 patients.
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four patients, was nondiagnostic in nine, and benign in 44
patients (Table 2).
Based on ultrasonography, 50% of the parathyroid ade-
nomas were on the left side and 85.5% were located infe-
riorly. The mean parathyroid adenoma size was
14.04  6.1 mm (range, 6e41.3 mm). Tc99m sestamibi
scintigraphy was also performed in all patients and the
parathyroid adenoma was localized in 114 (82.6%) patients.
3.2. Postoperative results
Based on the histopathology results, 128 (92.8%) patients
had parathyroid adenomas. Six patients had atypical ade-
nomas and three patients had hyperplasia. In one patient,
parathyroid carcinoma was diagnosed histopathologically.
The postoperative parathyroid histopathology results are
shown in Table 3.
Thirty-two (23.2%) patients underwent para-
thyroidectomy, whereas 106 (76.8%) patients underwent
both parathyroidectomy and thyroidectomy. Among 32 pa-
tients who underwent only parathyroidectomy, US findingsTable 2 Fine needle aspiration biopsy results of thyroid
nodules in patients with primary hyperparathyroidism.
FNAB results n (%)
Benign 44 (75.9%)
AUS/FLUS 4 (6.9%)
Suspicious for malignancy 1 (1.7%)
Nondiagnostic 9 (15.5%)
AUS, atypia of undetermined significance; FLUS, follicular lesion
of undetermined significance; FNAB, fine-needle aspiration bi-
opsy.
The sample comprises 58 patients.
Please cite this article in press as: Cuhaci N, et al., Concomitant thy
Journal of Surgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.10were chronic thyroiditis in 17 patients, normal in seven
patients, and MNG/NG in eight patients (the nodules were
less than 1 cm and not ultrasonographically questionable).
Lobectomy/isthmechtomy was performed in 35 patients
and total thyroidectomy was performed in 71 patients. In
the lobectomy group; preoperative US findings were chronic
thyroiditis in 13 patients (five of these patients had Graves’
disease), normal in two patients, NG in 10 patients, and
chronic thyroiditis with NG in 10 patients. In this group,
lobectomy was performed in 10 patients because of tech-
nical problems (8 of these patients had chronic thyroiditis
and two of these patients had normal US findings preoper-
atively). In the total thyroidectomy group, the preoperative
US findings were chronic thyroiditis in seven patients, MNG
in seven patients, and chronic thyroiditis with MNG/giant
nodule in 57 patients. In seven patients with chronic
thyroiditis, indications for total thyroidectomy were
Graves’ disease in one patient, diffuse enlarged thyroid
gland and cosmetic concern in two patients, compression
symptoms in one patient, family history of thyroid cancer in
one patient, and failure of intraoperative detection of the
parathyroid adenoma in two patients (Table 4).
The postoperative thyroid histopathology results
revealed that 79.2% of patients had benign thyroid disease
and 22 (20.8%) patients had malignant thyroid disease. All
patients with malignant disease had papillary thyroidroid lesions in patients with primary hyperparathyroidism, Asian
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Table 4 Preoperative thyroid ultrasonography findings in
patients with primary hyperparathyroidism who underwent
lobectomy and total thyroidectomy.
Variables Lobectomy
(35 patients)
Total
thyroidectomy
(71 patients)
Thyroid US results
Normal 2 (5.7%) d
MNG/NG 10 (28.6%) 7 (9.9%)
Chronic thyroiditis þ
MNG/NG
10 (28.6%) 57 (80.2%)
Chronic thyroiditis 13 (37.1%) 7 (9.9%)
MNG, multinodular goiter; NG, nodular goiter; US, ultrasonog-
raphy.
The data are presented as the number (%).
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carcinoma. In the remaining two patients, the tumor size
was greater than 1 cm. One of these patients had follicular
variant and the other patient had the tall cell variant of
PTC. 2 of the four patients with AUS/FLUS had benign and
two patients had malignant histopathology results (1 of
patient had papillary microcarcinoma and one patient had
follicular variant PTC). Tall cell variant PTC was diagnosed
in the patient with the suspected malignancy indicated by
the FNAB result. Among nine patients with nondiagnostic
FNAB results, three patients had papillary microcarcinoma.
Papillary carcinoma was found incidentally in four patients
with preoperative chronic thyroiditis, based on the US
result. In eight patients, FNAB was benign preoperatively,
but histopathologically PTC was detected. In the remaining
four patients with final thyroid malignancy, preoperative
FNAB was not performed because nodules were smaller
than 1 cm. One patient with PTC had lymph node metas-
tasis. A total of 63.6% of PTC were on the same side with
the parathyroid adenoma. The operation type and post-
operative thyroid histopathology results are shown in Table
3. Ultrasonography had a Sn of 89.1% and Tc99m sestamibi
had a Sn of 82.6% for the detection of parathyroid
adenomas.
4. Discussion
In this study, we aimed to evaluate the prevalence of
concomitant thyroid disease and thyroid malignancy in
patients who underwent surgical treatment for PHPT to
highlight the best surgical strategy in this group of patients.
We also evaluated the Sn of neck US and Tc99m sestamibi
scintigraphy for detecting parathyroid adenomas. We also
attempted to determine the clinical impact of preoperative
neck US in patients with PHPT.
In this study, preoperative US revealed that among all
patients with PHPT, 93.5% of the patients had thyroid ab-
normalities and 66.7% of the patients had at least one
thyroid nodule. The postoperative malignancy rate was
20.8%.
In the literature, the prevalence of thyroid disease with
concomitant PHPT ranges from 18% to 84.3%; in addition,
thyroid carcinoma has been reported in 1e36% of patientsPlease cite this article in press as: Cuhaci N, et al., Concomitant thy
Journal of Surgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.10with PHPT.2,4,7,11e13,26,27 Strichartz and Giuliano evaluated
308 patients who underwent operations for PHPT and
revealed that 17% of patients had histologically proven
thyroid disease and 4% of patients had differentiated thy-
roid cancer.11 These wide variations were probably because
of the variations in patient selection, surgical indications,
examination methods, and the number of patients.13,26 The
true incidence of PTC in patients with PHPT is unknown
because not all patients with PHPT undergo surgery, and
neck exploration is impossible during a MIA, which has
become more common in recent years.28 Our higher fre-
quency of concomitant thyroid disease and thyroid malig-
nancy in patients with PHPT is probably because of the fact
that our clinic is a highly specialized thyroid reference
center in our region, preoperative thyroid examination by
US is performed routinely for these patients, and thyroid-
ectomy is performed with a higher rate. Masatsugu et al.18
showed that of 109 patients with sporadic PHPT, 52.3% of
these patients had concomitant thyroid disease and 17.4%
of these patients had NMTC. They explained this high fre-
quency by the fact that the patients who visited their
center had potential thyroid disease similar to ours.18
The curative treatment of PHPT is surgical excision of
the enlarged parathyroid gland.17,26 The surgical approach
has changed during the past 10 years owing to improved
preoperative imaging techniques and the availability of
intraoperative PTH assay.17,18,29 In particular, the approach
has moved from bilateral neck exploration to a unilateral
MIA or limited neck exploration.11,17,18,26,30 The potential
advantages of MIA include the possible use of local anes-
thesia; a reduction in the operation time of up to 50%,
lower incidence of hypocalcemia; and decreased hospital-
ization time, complication rates, and hospital charges.17 A
MIA would not be considered in a patient with a history of
head and neck irradiation, a family history of thyroid can-
cer, or a nonlocalizable parathyroid abnormality on pre-
operative imaging studies.4 In addition, the main challenge
of MIA is concomitant thyroid nodules.31,32 For a successful
MIA, it is important to evaluate certain points, including
whether the parathyroid adenoma is solitary, the position
of the parathyroid adenoma, and the presence of possible
concomitant thyroid nodular diseases.26 If there is thyroid
disease, clinical decision and management of the patients
may change.26
In our study 106 patients underwent thyroidectomy
because of the toxic MNG/Graves’ disease, MNG/NG or
giant nodule, or questionable or nondiagnostic FNAB re-
sults. However, 12 patients had thyroidectomy because of
technical reasons.
Evaluating the thyroid gland before an operation for
PHPT is essential because a delay in operation of the thy-
roid lesion can result with increased morbidity associated
with a second neck exploration.26 It is important that pa-
tients with unexpected thyroid malignancy be treated
safely at the time of the initial operation for hyperpara-
thyroidism.4 Previous studies11 have revealed that thyroid
lesions of less than 1 cm are missed in 94% of patients and
that lesions 1e2 cm are missed in 50% of patients with neck
exploration. The preoperative absence of a palpable thy-
roid abnormality is insufficient to exclude thyroid disease.
Many endocrine surgeons have recommended neck US
before parathyroid surgery for preoperative localization toroid lesions in patients with primary hyperparathyroidism, Asian
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a study by Gates et al4, preoperative thyroid US altered the
operative management in nine (38%) of 24 patients who
underwent surgery for PHPT; three of these nine (33%)
patients had differentiated thyroid carcinoma. This finding
suggests that preoperative neck US is useful for preopera-
tive management in patients with PHPT.4 Preoperative neck
US in these patients can also eliminate the operative
morbidity of the second operation.4
It has been determined that preoperative Tc99m sesta-
mibi and US findings represent a reliable localization
technique for parathyroid lesions when used together, and
result in a nearly 90% true-positive rate.26 Tc99m sestamibi
is useful for the localization of enlarged parathyroid glands;
however, its Sn and positive predictive value were unsat-
isfactory in patients with concomitant thyroid disease26 and
in patients with small parathyroid adenomas.18 Concomi-
tant thyroid disease reportedly affects the detection of
parathyroid lesions with a decrease in Sn ranging from 71%
to 80% for Tc99m sestamibi and 53% to 77% for US.18 The Sn
of US in parathyroid lesions ranges from 30% to 90%.33 Ul-
trasonography is a useful diagnostic tool for the detection
of concomitant thyroid nodules18; however, US cannot al-
ways detect glands deep in the neck or glands with ectopic
localization, it is operator-dependent, and it has a limited
scanning field.5,18 Mazzeo et al34 found that US and Tc99m
sestamibi have similar diagnostic value with respect to
detecting parathyroid lesions in patients without thyroid
abnormalities (85% vs. 82%, respectively) and in patients
with concomitant thyroid disease (77% vs. 80%, respec-
tively). In patients with multigland disease, US appeared to
be superior to scintigraphy (70% vs 40%).35,36 By contrast,
various studies show that Tc99m sestamibi is superior to US
in patients with or without thyroid abnormalities.34,37 In a
meta-analysis, the Sn and specificity (Sp) of MIBI were
determined as 90.7% and 98.8%, respectively, and these
findings suggested that more than 80% of patients with
PHPT would be candidates for a MIA.17 In our study, US had
a Sn of 89.1% and MIBI had a Sn of 82.6% for detecting
parathyroid lesions.
The main reason for the high prevalence of concomi-
tant thyroid disease and malignancy in PHPT remains un-
clear. Some authors have suggested that it can be
coincidental, whereas others claim that this relationship
may be because of increased endogenous Ca concentra-
tion, growth factors, epithelial growth factor, or goitro-
genic factors.26 Some other authors have suggested that
previous head and neck irradiation may be a common
pathogenetic factor for the development of both PHPT and
NMTC.1 In our study, no patient had undergone head or
neck irradiation.
In conclusion, thyroid disease and thyroid malignancy
have a high frequency in patients with PHPT. We recom-
mend the routine use of US in combination with Tc99m
sestamibi, particularly in endemic goiter regions, to detect
any concomitant thyroid disease and thus determine the
best surgical strategy in patients with PHPT.Acknowledgements
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